ATE327228T1 - Substituierte 2-(2,6-dioxo-3-fluoropiperidine-3- yl)-isoindoline und ihre verwendung zum reduzieren des tnf-alpha spiegels - Google Patents

Substituierte 2-(2,6-dioxo-3-fluoropiperidine-3- yl)-isoindoline und ihre verwendung zum reduzieren des tnf-alpha spiegels

Info

Publication number
ATE327228T1
ATE327228T1 AT02028237T AT02028237T ATE327228T1 AT E327228 T1 ATE327228 T1 AT E327228T1 AT 02028237 T AT02028237 T AT 02028237T AT 02028237 T AT02028237 T AT 02028237T AT E327228 T1 ATE327228 T1 AT E327228T1
Authority
AT
Austria
Prior art keywords
dioxo
isoindolines
fluoropiperidine
substituted
alpha levels
Prior art date
Application number
AT02028237T
Other languages
English (en)
Inventor
George W Muller
David I Stirling
Roger Shen-Chu Chen
Hon-Wah Man
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/976,140 external-priority patent/US5874448A/en
Priority claimed from US09/042,274 external-priority patent/US5955476A/en
Application filed by Celgene Corp filed Critical Celgene Corp
Application granted granted Critical
Publication of ATE327228T1 publication Critical patent/ATE327228T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02028237T 1997-11-18 1998-11-17 Substituierte 2-(2,6-dioxo-3-fluoropiperidine-3- yl)-isoindoline und ihre verwendung zum reduzieren des tnf-alpha spiegels ATE327228T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/976,140 US5874448A (en) 1997-11-18 1997-11-18 Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNFα levels
US09/042,274 US5955476A (en) 1997-11-18 1998-03-13 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels

Publications (1)

Publication Number Publication Date
ATE327228T1 true ATE327228T1 (de) 2006-06-15

Family

ID=26719049

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02028237T ATE327228T1 (de) 1997-11-18 1998-11-17 Substituierte 2-(2,6-dioxo-3-fluoropiperidine-3- yl)-isoindoline und ihre verwendung zum reduzieren des tnf-alpha spiegels
AT98958016T ATE233753T1 (de) 1997-11-18 1998-11-17 Substituierte 2-(2,6-dioxo-3-fluoropiperidin-3- yl)-isoindoline und ihre verwendung zur verminderung des tnfa spiegels

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT98958016T ATE233753T1 (de) 1997-11-18 1998-11-17 Substituierte 2-(2,6-dioxo-3-fluoropiperidin-3- yl)-isoindoline und ihre verwendung zur verminderung des tnfa spiegels

Country Status (14)

Country Link
EP (3) EP1308444B1 (de)
AT (2) ATE327228T1 (de)
AU (1) AU752958B2 (de)
CY (1) CY1106100T1 (de)
CZ (1) CZ299808B6 (de)
DE (2) DE69811962T2 (de)
DK (1) DK1308444T3 (de)
ES (2) ES2262753T3 (de)
FI (1) FI20001192L (de)
HK (1) HK1054381B (de)
NO (1) NO318737B1 (de)
PT (1) PT1308444E (de)
SI (1) SI1308444T1 (de)
SK (1) SK7382000A3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200101500T2 (tr) * 1998-03-16 2002-06-21 Celgene Corporation 2-(2,6-dioksopiperidin-3-il)izoindolin türevleri, bunların hazırlanması ve enflamatuarn sitokinlerin inhibitörleri olarak kullanımı.
US20050100529A1 (en) * 2003-11-06 2005-05-12 Zeldis Jerome B. Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1531492A (en) * 1991-02-14 1992-09-15 Rockefeller University, The Method for controlling abnormal concentration tnf alpha in human tissues
US5629327A (en) * 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines
DE4422237A1 (de) * 1994-06-24 1996-01-04 Gruenenthal Gmbh Verwendung von Lactamverbindungen als pharmazeutische Wirkstoffe
DE19613976C1 (de) * 1996-04-09 1997-11-20 Gruenenthal Gmbh Thalidomid-Prodrugs mit immunmodulatorischer Wirkung
DE69740140D1 (de) * 1996-07-24 2011-04-14 Celgene Corp Substituierte 2-(2,6-Dioxopiperidin-3-yl)-phthalimide und Oxoisoindoline und Verfahren zur Verringerung der TNF-Alpha-Stufen
HU228769B1 (en) * 1996-07-24 2013-05-28 Celgene Corp Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and their use for production of pharmaceutical compositions for mammals to reduce the level of tnf-alpha
US5635517B1 (en) * 1996-07-24 1999-06-29 Celgene Corp Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines

Also Published As

Publication number Publication date
DE69811962T2 (de) 2003-08-28
HK1054381A1 (en) 2003-11-28
CZ20001822A3 (cs) 2000-11-15
ES2192342T3 (es) 2003-10-01
HK1054381B (en) 2006-10-13
EP1062214B1 (de) 2003-03-05
FI20001192A7 (fi) 2000-07-14
AU1413899A (en) 1999-09-27
EP1710242A1 (de) 2006-10-11
PT1308444E (pt) 2006-08-31
ATE233753T1 (de) 2003-03-15
ES2262753T3 (es) 2006-12-01
NO318737B1 (no) 2005-05-02
EP1308444A1 (de) 2003-05-07
SI1308444T1 (sl) 2007-04-30
DE69834668D1 (de) 2006-06-29
DE69811962D1 (de) 2003-04-10
NO20002529D0 (no) 2000-05-16
AU752958B2 (en) 2002-10-03
SK7382000A3 (en) 2000-12-11
FI20001192L (fi) 2000-07-14
CZ299808B6 (cs) 2008-12-03
CY1106100T1 (el) 2011-06-08
NO20002529L (no) 2000-06-30
DK1308444T3 (da) 2006-09-18
EP1062214A1 (de) 2000-12-27
EP1308444B1 (de) 2006-05-24
DE69834668T2 (de) 2007-01-11

Similar Documents

Publication Publication Date Title
TR200002627T2 (tr) İkameli 2-(2,6- (Diokso-3-floropiperidin-3-İI) -izoindolinler ve TNF alfa seviyelerini düşürmek için kullanılmaları
PL332867A1 (en) Substituted 2-(2-2,6-dioxopiperidin-3-yl)phtalamides and 1-oxoisoindolins as well as method of lowering the tnf-alpha level
TR200000107T2 (tr) Sübstitüe edilmiş 2-(2,6-dioksopiperidin-3-il) -ftalimidler ve -1-oksoizoindolinler ve TNF alfa seviyelerini düşürmek için yöntem.
DK2305248T3 (da) Substituerede phenethylsulfoner og fremgangsmåde til reduktion af tnf-alfa-niveauer
FR2750041B3 (fr) Lit pour malade
FI935020A7 (fi) Interleukiini-1b-proteaasi ja interleukiini-1b-proteaasin inhibiittoreita
DK0720609T3 (da) 3-(5-Tetrazolylbenzyl)aminoperidinderivater og antagonister for tachykininer
DK651889A (da) Vekselretterkredsloeb og fremgangsmaade til dets styring
DE69723984D1 (de) Inhibitoren der produktion von s-cd23 und der secretion von tnf
NO913739D0 (no) Stein- og overlastsikringsanordning for ploger.
DE69834668D1 (de) Substituierte 2-(2,6-dioxo-3-fluoropiperidine-3-yl)-isoindoline und ihre Verwendung zum reduzieren des TNF-alpha spiegels
DK2070920T3 (da) Substituerede 2-(2,6-dioxopiperidin-3-yl)phthalimider og 1-oxoisoindoliner og fremgangsmåde til at reducere TNF-a-niveauer
KR950026963U (ko) 벽돌 및 블럭 조적기의 파레트공급장치
KR970053565U (ko) 찜질용 돌 매트리스
ITMI921464A1 (it) Copolimeri stirene-anidride maleica immidizzati e salificati
MX9100939A (es) Bloques de diferentes medidas de cemento y jaltete.
NO944940D0 (no) Brosten med siderettede avstandsholdere
KR950010081U (ko) 흑화로용 하부로체의 승강장치

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1308444

Country of ref document: EP

REN Ceased due to non-payment of the annual fee